Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 4186-4192

  Mott, Tiffany ^a   Soler, Michael ^a   Grigsby, Sierrah ^a   Medley, Ronald ^b   Whitlock, Gregory C ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; SECRETORY PROTEIN;

ARTICLE; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA MULTIVORANS; COMPUTER MODEL; CONTROLLED STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SUPERNATANT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA CEPACIA COMPLEX; CULTURE MEDIA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS;

EID: 78049495029     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00577-10     Document Type: Article

References (26)

1. Andersen, P., D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron. 1991. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 59:1905-1910.
2. Carvalho, A. P., G. M. Ventura, C. B. Pereira, R. S. Leao, T. W. Folescu, L. Higa, L. M. Teixeira, M. C. Plotkowski, V. L. Merquior, R. M. Albano, and E. A. Marques. 2007. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different pro- files of exoenzyme production. APMIS 115:311-318.
3. Chu, K. K., D. J. Davidson, T. K. Halsey, J. W. Chung, and D. P. Speert. 2002. Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect. Immun. 70:2715-2720.
4. Coenye, T., E. Mahenthiralingam, D. Henry, J. J. LiPuma, S. Laevens, M. Gillis, D. P. Speert, and P. Vandamme. 2001. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int. J. Syst. Evol. Microbiol. 51:1481-1490.
5. Decker, T., and M. L. Lohmann-Matthes. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 115:61-69.
6. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
7. Hathout, Y. 2007. Approaches to the study of the cell secretome. Expert Rev. Proteomics 4:239-248.
8. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
9. Lewin, L. O., P. J. Byard, and P. B. Davis. 1990. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J. Clin. Epidemiol. 43:125-131.
10. Lory, S. 1992. Determinants of extracellular protein secretion in gramnegative bacteria. J. Bacteriol. 174:3423-3428.
11. Mahenthiralingam, E., J. Bischof, S. K. Byrne, C. Radomski, J. E. Davies, Y. Av-Gay, and P. Vandamme. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38:3165-3173.
12. Mahenthiralingam, E., T. A. Urban, and J. B. Goldberg. 2005. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 3:144-156.
13. Malen, H., F. S. Berven, K. E. Fladmark, and H. G. Wiker. 2007. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics 7:1702-1718.
14. Mariappan, V., K. M. Vellasamy, J. S. Thimma, O. H. Hashim, and J. Vadivelu. 2010. Identification of immunogenic proteins from Burkholderia cepacia secretome using proteomic analysis. Vaccine 28:1318-1324.
15. McMenamin, J. D., T. M. Zaccone, T. Coenye, P. Vandamme, and J. J. LiPuma. 2000. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 117:1661-1665.
16. Parke, J. L., and D. Gurian-Sherman. 2001. Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. Annu. Rev. Phytopathol. 39:225-258.
17. Riedel, K., P. Carranza, P. Gehrig, F. Potthast, and L. Eberl. 2006. Towards the proteome of Burkholderia cenocepacia H111: setting up a 2-DE reference map. Proteomics 6:207-216.
18. Seed, K. D., and J. J. Dennis. 2005. Isolation and characterization of bacteriophages of the Burkholderia cepacia complex. FEMS Microbiol. Lett. 251:273-280.
19. Shelly, D. B., T. Spilker, E. J. Gracely, T. Coenye, P. Vandamme, and J. J. LiPuma. 2000. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J. Clin. Microbiol. 38:3112-3115.
20. Sibbald, M. J., A. K. Ziebandt, S. Engelmann, M. Hecker, A. de Jong, H. J. Harmsen, G. C. Raangs, I. Stokroos, J. P. Arends, J. Y. Dubois, and J. M. van Dijl. 2006. Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol. Mol. Biol. Rev. 70:755-788.
21. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat. Med. 1:661-666.
22. Tablan, O. C., T. L. Chorba, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Gilligan, W. M. Morgan, L. A. Carson, W. J. Martone, J. M. Jason, et al. 1985. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J. Pediatr. 107:382-387.
23. Trost, M., D. Wehmhoner, U. Karst, G. Dieterich, J. Wehland, and L. Jansch. 2005. Comparative proteome analysis of secretory proteins from pathogenic and nonpathogenic Listeria species. Proteomics 5:1544-1557.
24. Turton, J. F., N. Arif, D. Hennessy, M. E. Kaufmann, and T. L. Pitt. 2007. Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars. J. Clin. Microbiol. 45:3105-3108.
25. van Pelt, C., C. M. Verduin, W. H. Goessens, M. C. Vos, B. Tummler, C. Segonds, F. Reubsaet, H. Verbrugh, and A. van Belkum. 1999. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J. Clin. Microbiol. 37:2158-2164.
26. Vermis, K., T. Coenye, E. Mahenthiralingam, H. J. Nelis, and P. Vandamme. 2002. Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J. Med. Microbiol. 51:937-940.